ArticleParasites & vectors2026
Contrasting shifts in potential climatic suitability of two Thelazia callipaeda vectors (Phortica okadai and Phortica variegata) across China and Europe under climate change.
Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundPhortica okadai and Phortica variegata are the primary vectors of the zoonotic eyeworm Thelazia callipaeda, which infects humans and various mammals. Climate change and intensified human activities have altered the potential suitable habitats of these vectors, posing a risk of expanded T. callipaeda transmission. This study aims to predict the current potential suitable habitats and future distribution patterns of the two species, providing a scientific basis for vector-borne disease prevention and control.
methodsSpecies occurrence records were compiled from the Global Biodiversity Information Facility (GBIF; https://www.gbif.org/ ) and systematic literature reviews. The MaxEnt model was utilized to identify key environmental determinants influencing vector distribution. Climate data from WorldClim, future climate scenarios (SSP1-2.6, SSP2-4.5, SSP5-8.5), elevation data, and Human Footprint Index (HFP) were integrated to predict potential suitable habitats and future distributions (2041-2060) across China and Europe.
resultsThe key environmental drivers for P. okadai are warmest quarter precipitation, HFP, and temperature seasonality, and for P. variegata they are HFP, coldest quarter precipitation, and temperature annual range. Currently, the suitable habitats of P. okadai are concentrated in central, eastern, and northeastern coastal China, with only sporadic low-suitability patches recorded in Europe. P. variegata exhibits a wide distribution across the UK, France, Belgium, and Italy, with nearly the entire Mediterranean coastal belt and its associated offshore islands falling within its suitable range. Under future climate scenarios, the suitable area of P. okadai is projected to expand significantly in Central/Western Europe (Italy, Austria, Switzerland, and western Russia). In contrast, the suitable habitats of P. variegata will shift significantly: The central-southern-eastern European transitional belt will lose almost all suitable habitat across scenarios, while the Mediterranean littoral and its offshore islands remain climatically suitable.
conclusionsThe suitable area for P. okadai is projected to increase significantly, whereas that for P. variegata is expected to decline. Temperature and precipitation emerge as primary drivers of these contrasting distribution shifts. These findings underscore the need for enhanced vector surveillance and control strategies for T. callipaeda, particularly regarding the expanding P. okadai populations in Europe.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.